Anika Therapeutics has appointed Richard Hague as chief commercial officer.
Spinal Tech
Here are 16 key notes on orthopedic and spine device companies over the past week.
Smith & Nephew has agreed to acquire Blue Belt Technologies for $275 million.
Regenexx announced the issuance of a United States patent for its proprietary same-day stem cell procedure.
ReVivo Medical, an Albany, N.Y.-based biomedical startup, received a $225,000 grant, according to the Albany Business Review.
Paradigm Spine commissioned a Miliman report titled, "Utilization and Cost for Surgery for Lumbar Spinal Stenosis in a Commercially Insured Population" that was recently published.
Zimmer Biomet reported net sales increased for the third quarter of 2015, shortly after the merger completed.
San Diego-based NuVasive reported its third quarter 2015 financial results ending on Sept. 30, 2015.
Ronda Stryker, director at Stryker, sold 12,000 shares of the company, according to a Financial Magazin report.
Zacks has downgraded RTI Surgical from a "buy" rating to a "hold" rating, according to a Dakota Financial News report.
